Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis.
Devasenapathy N, Chu A, Wong M, Srivastava A, Ceccacci R, Lin C, MacDonald M, Wen A, Steen J, Levine M, Pyne L, Schneider L, Chu DK; AAAAI/ACAAI Joint Task Force on Practice Parameters for Atopic Dermatitis Guideline Development Group.
Devasenapathy N, et al. Among authors: wong m.
Lancet Child Adolesc Health. 2023 Jan;7(1):13-25. doi: 10.1016/S2352-4642(22)00283-8. Epub 2022 Nov 10.
Lancet Child Adolesc Health. 2023.
PMID: 36370744